The device uses thermographic monitoring of a patient's feet to identify early onset of diabetic foot ulcers, which can lead to limb loss if not detected early.
The partnership will provide personalized diabetes support with the protection of life insurance and the potential to earn up to 25% in premium savings.
The collaboration combines Abbott′s glucose sensing technology with Omada Health's proprietary digital coaching platform to provide personalized care.
The contract will cover eligible members who are living with Type 1 or Type 2 diabetes, covering 5.3 million federal employees, retirees and their families.
The company's implantable system is the only long-term CGM that lasts up to 90 days; it is now available for $99 plus the cost of the sensor placement.
The diabetes risk was calculated from the analysis of data 23andMe collected from more than 2.5 million customers who opted in to its research.
The OneTouch Reveal mobile app can now spot recurring high or low patterns and automatically notify users so they can take action to avoid them in the future.
Researchers used data from 14,000 Apple Watch users and was able to detect that 462 of them had diabetes by using the Watch's heart rate sensor.
The small size of the flexible, bandage-like pump would reduce barriers to using automated insulin-delivery systems.
The company worked with Truven Health Analytics to show that BlueStar can save on average a range of $254 to $271 per user per month.